OKWAVE, Inc. (XNGO:3808)
Japan
· Delayed Price · Currency is JPY 58.00
+6.00 (11.54%)
At close: Apr 18, 2025
OKWAVE Revenue
OKWAVE had revenue of 55.00M JPY in the quarter ending December 31, 2024, with 34.15% growth. This brings the company's revenue in the last twelve months to 171.00M, up 12.50% year-over-year. In the fiscal year ending June 30, 2024, OKWAVE had annual revenue of 152.00M with 4.11% growth.
Revenue (ttm)
171.00M
Revenue Growth
+12.50%
P/S Ratio
13.81
Revenue / Employee
11.40M
Employees
15
Market Cap
2.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 152.00M | 6.00M | 4.11% |
| Jun 30, 2023 | 146.00M | -686.00M | -82.45% |
| Jun 30, 2022 | 832.00M | -1.36B | -62.11% |
| Jun 30, 2021 | 2.20B | -2.60B | -54.20% |
| Jun 30, 2020 | 4.80B | -97.00M | -1.98% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Toyota Motor | 46.75T |
| Sony Group | 13.81T |
| Mitsubishi UFJ Financial Group | 6,199.27B |
| Hitachi | 9,521.78B |
| Fast Retailing | 3,295.04B |
| Keyence | 1,035.29B |
| Chugai Pharmaceutical | 1,170.61B |
| Sumitomo Mitsui Financial Group | 4,244.87B |